AJP - Endo Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 263: E355-E361, 1992;
0193-1849/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Healy, D. P.
Right arrow Articles by Schachter, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Healy, D. P.
Right arrow Articles by Schachter, B. S.

AJP - Endocrinology and Metabolism, Vol 263, Issue 2 E355-E361, Copyright © 1992 by American Physiological Society

ARTICLES

Stimulation of angiotensinogen mRNA levels in rat pituitary by estradiol

D. P. Healy, M. Q. Ye, L. X. Yuan and B. S. Schachter
Department of Pharmacology, Mount Sinai School of Medicine, City University of New York, New York 10029.

Angiotensin II (ANG II) is a putative paracrine hormone in the anterior pituitary. Angiotensinogen mRNA, however, is not detectable by Northern blot hybridization, suggesting that ANG II may not be synthesized within the pituitary. An alternative explanation may be that angiotensinogen gene activity is low under normal conditions, with angiotensinogen mRNA being below the level of detection. Utilizing a sensitive solution hybridization method, we sought to determine whether angiotensinogen mRNA could be detected in pituitaries from normal male rats or ovariectomized (OVX) rats treated with estradiol (E2) for 4 days. Very low levels of angiotensinogen mRNA were detected from male or OVX rat pituitaries, but E2 treatment resulted in a marked dose-dependent increase in pituitary angiotensinogen mRNA levels. Levels of angiotensinogen within the pituitary were not significantly different after the E2 treatment. Angiotensinogen mRNA levels in liver and brain were much higher than in the pituitary but were not altered significantly by the chronic E2 treatment. These results are consistent with the local synthesis of angiotensinogen in the pituitary and further suggest that pituitary angiotensinogen gene transcription is regulated by estrogen.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. Suarez, G. Diaz-Torga, A. Gonzalez-Iglesias, C. Cristina, and D. Becu-Villalobos
Upregulation of angiotensin II type 2 receptor expression in estrogen-induced pituitary hyperplasia
Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E786 - E794.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. C. Speth, M. S. Smith, and K. L. Grove
Lactation decreases angiotensinogen mRNA expression in the midcaudal arcuate nucleus of the rat brain
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1169 - R1176.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. Diaz-Torga, A. G. Iglesias, R. Achaval-Zaia, C. Libertun, and D. Becu-Villalobos
Angiotensin II-induced Ca2+ mobilization and prolactin release in normal and hyperplastic pituitary cells
Am J Physiol Endocrinol Metab, March 1, 1998; 274(3): E534 - E540.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online